Join to View Full Profile
2301 Renaissance BlvdRn0320King of Prussia, PA 19406
Phone+1 610-787-3490
Fax+1 610-787-7043
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Myron Chu, DO is a rheumatologist in King of Prussia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and Indiana.
Education & Training
Loma Linda University Health Education ConsortiumFellowship, Rheumatology, 1995 - 1997
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1992 - 1995
TMC Health Medical Education , Inc. (THMEP)Internship, Transitional Year, 1991 - 1992
College of Osteopathic Medicine of the PacificClass of 1991
Certifications & Licensure
CA State License 1995 - 2028
AZ State License 1992 - 2027
IN State License 1998 - 2027
NJ State License 2000 - 2027
PA State License 2002 - 2026
Publications & Presentations
PubMed
- 12 citationsA Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-...Stanley Cohen, Jean S Beebe, Vishala Chindalore, Shunjie Guan, Mina Hassan-Zahraee
Arthritis Research & Therapy. 2024-06-06 - 12 citationsPhase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang
RMD Open. 2022-04-01 - 5 citationsThe effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study.Sang-Cheol Bae, Damon L Bass, Myron Chu, Paula Curtis, Richard Dimelow
Arthritis Research & Therapy. 2022-02-16
